Genomma Lab Internacional, S.A.B. de C.V. Share Price
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Mexican S.E.
04/11/2026
|
5-day change | 1st Jan Change | ||
| 15.49 MXN | +2.51% |
|
+6.90% | -13.42% |
| Market Cap | 1.51TCr 81Cr 72Cr 66Cr 60Cr 112.9Cr 7.64TCr 115.48Cr 789.84Cr 316.63Cr 4.04TCr 303.54Cr 297.04Cr 13TCr | P/E 2026 * |
7.96x | P/E 2027 * | 7.84x |
|---|---|---|---|---|---|
| Enterprise Value | 1.93TCr 103.34Cr 92Cr 84Cr 77Cr 144.28Cr 9.77TCr 147.57Cr 1.01TCr 404.63Cr 5.17TCr 387.89Cr 379.6Cr 16TCr | EV / Sales 2026 * |
1.08x | EV / Sales 2027 * | 1x |
| Free-Float |
68.95% | Yield 2026 * |
5.17% | Yield 2027 * | 6.92% |
| Markets | Quality | ||
|---|---|---|---|
Mexican S.E.
| LAB B | End-of-day quote | |
OTC Markets
| GNMLF | Delayed | |
|
Deutsche Boerse AG
| GEKA | Delayed |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | +2.51% | ||
| 1 week | +6.90% | ||
| Current month | +2.31% | ||
| 1 month | +20.83% | ||
| 3 months | +6.53% | ||
| 6 months | -5.32% | ||
| Current year | -13.42% |
| 1 week | 14.6 |  | 15.63 |
| 1 month | 12.53 | | 15.75 |
| Current year | 12.22 | | 19.48 |
| 1 year | 12.22 | | 19.48 |
| 3 years | 12.22 | | 29.18 |
| 5 years | 12.22 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 12/04/2023 |
| Director of Finance/CFO | - | 01/12/2015 | |
| Investor Relations Contact | - | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/10/1996 | |
Juan Alonso
BRD | Director/Board Member | - | 06/07/2010 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.51% | +6.90% | -12.93% | +9.62% | 81Cr | |
| +0.61% | +10.07% | +56.36% | +149.73% | 1,26300Cr | |
| +3.81% | +1.95% | +47.88% | +82.58% | 67TCr | |
| +3.09% | +3.09% | +36.56% | +108.48% | 52TCr | |
| -0.67% | -2.14% | +48.28% | +65.76% | 39TCr | |
| +3.93% | +6.69% | +79.30% | +45.44% | 37TCr | |
| -0.31% | +1.22% | +31.84% | +58.97% | 31TCr | |
| +0.58% | +8.17% | +13.40% | +37.39% | 29TCr | |
| +3.73% | +5.90% | +61.27% | +77.31% | 26TCr | |
| +4.19% | +9.60% | +41.85% | +113.85% | 22TCr | |
| Average | +1.03% | +5.72% | +40.38% | +74.91% | 42.86TCr | |
| Weighted average by Cap. | +0.84% | +5.96% | +48.73% | +97.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.78TCr 95Cr 85Cr 78Cr 71Cr 133.33Cr 9.03TCr 136.37Cr 932.73Cr 373.91Cr 4.78TCr 358.45Cr 350.78Cr 15TCr | 1.87TCr 100.51Cr 90Cr 82Cr 75Cr 140.32Cr 9.5TCr 143.53Cr 981.69Cr 393.54Cr 5.03TCr 377.26Cr 369.19Cr 16TCr |
| Net income | 195.07Cr 10Cr 9.32Cr 8.55Cr 7.77Cr 15Cr 988.78Cr 15Cr 102.19Cr 41Cr 523.33Cr 39Cr 38Cr 1.66TCr | 205.8Cr 11Cr 9.84Cr 9.02Cr 8.2Cr 15Cr 1.04TCr 16Cr 107.81Cr 43Cr 552.11Cr 41Cr 41Cr 1.75TCr |
| Net Debt | 419.02Cr 22Cr 20Cr 18Cr 17Cr 31Cr 2.12TCr 32Cr 219.5Cr 88Cr 1.12TCr 84Cr 83Cr 3.56TCr | 366.55Cr 20Cr 18Cr 16Cr 15Cr 27Cr 1.86TCr 28Cr 192.02Cr 77Cr 983.35Cr 74Cr 72Cr 3.12TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | MX$15.49 | +2.51% | 28,51,420 |
| 03/26/03 | MX$15.11 | -0.20% | 43,49,870 |
| 30/26/30 | MX$15.14 | +1.54% | 36,39,970 |
| 29/26/29 | MX$14.91 | +2.90% | 33,40,451 |
| 28/26/28 | MX$14.49 | -6.03% | 43,43,601 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
